Bebetter Med Inc
Clinical trials sponsored by Bebetter Med Inc, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can a new targeted pill boost chemotherapy against a tough lung cancer? Results expected Jun 2027 (estimated)
-
Can a new drug shrink Hard-to-Treat lymphoma tumors?
Disease control CompletedThis phase II trial is testing an experimental drug called BEBT-908 in adults with diffuse large B-cell lymphoma that has come back or not responded to at least two prior treatments. The study aims to see how well BEBT-908 shrinks tumors and controls the disease, as well as how s…
Phase 2 • Sponsor: BeBetter Med Inc • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Can a new pill tame advanced breast cancer?
Disease control CompletedThis early-stage trial is testing an experimental drug called BEBT-209 in women with advanced HR+/HER2- breast cancer. The study aims to find the safest dose and see how well the drug works, both on its own and when combined with standard hormone therapies like letrozole or fulve…
Phase 1 • Sponsor: BeBetter Med Inc • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Can a pill target a common cancer mutation?
Disease control CompletedThis early-stage trial is testing an experimental pill called BEBT-607 in adults with advanced or metastatic solid tumors that have a specific genetic change known as KRAS G12C. The study aims to find the safest dose and see whether the drug can shrink tumors or slow their growth…
Phase 1 • Sponsor: BeBetter Med Inc • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Can a new drug combo outsmart Triple-Negative breast cancer?
Disease control CompletedThis phase II trial is testing whether adding an experimental drug called BEBT-209 to standard chemotherapy (carboplatin and gemcitabine) can help people with advanced triple-negative breast cancer. The study will enroll about 65 women whose cancer has returned or spread and is n…
Phase 2 • Sponsor: BeBetter Med Inc • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC